Suppr超能文献

专用过滤器去除病毒的微观可视化:膜结构和捕获病毒颗粒定位的影响。

Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.

机构信息

Central Research Laboratory, Japanese Blood Products Organization, Kobe, Hyogo Prefecture, Japan.

Technology Development Department, Bioprocess Division, Asahi Kasei Medical Co. Ltd., Nobeoka, Miyazaki Prefecture, Japan.

出版信息

Biotechnol Prog. 2019 Nov;35(6):e2875. doi: 10.1002/btpr.2875. Epub 2019 Jul 3.

Abstract

Virus filtration with nanometer size exclusion membranes ("nanofiltration") is effective for removing infectious agents from biopharmaceuticals. While the virus removal capability of virus removal filters is typically evaluated based on calculation of logarithmic reduction value (LRV) of virus infectivity, knowledge of the exact mechanism(s) of virus retention remains limited. Here, human parvovirus B19 (B19V), a small virus (18-26 nm), was spiked into therapeutic plasma protein solutions and filtered through Planova™ 15N and 20N filters in scaled-down manufacturing processes. Observation of the gross structure of the Planova hollow fiber membranes by transmission electron microscopy (TEM) revealed Planova filter microporous membranes to have a rough inner, a dense middle and a rough outer layer. Of these three layers, the dense middle layer was clearly identified as the most functionally critical for effective capture of B19V. Planova filtration of protein solution containing B19V resulted in a distribution peak in the dense middle layer with an LRV >4, demonstrating effectiveness of the filtration step. This is the first report to simultaneously analyze the gross structure of a virus removal filter and visualize virus entrapment during a filtration process conducted under actual manufacturing conditions. The methodologies developed in this study demonstrate that the virus removal capability of the filtration process can be linked to the gross physical filter structure, contributing to better understanding of virus trapping mechanisms and helping the development of more reliable and robust virus filtration processes in the manufacture of biologicals.

摘要

纳米尺寸排阻膜(“纳米过滤”)的病毒过滤对于从生物制药中去除传染性病原体是有效的。虽然病毒去除过滤器的病毒去除能力通常基于病毒感染性的对数减少值(LRV)的计算来评估,但对病毒保留的确切机制的了解仍然有限。在这里,人细小病毒 B19(B19V),一种小病毒(18-26nm),被添加到治疗性血浆蛋白溶液中,并通过规模化生产工艺中的 Planova™15N 和 20N 过滤器进行过滤。通过透射电子显微镜(TEM)观察 Planova 中空纤维膜的宏观结构,发现 Planova 过滤器微孔膜具有粗糙的内表面、致密的中间层和粗糙的外表面。在这三层中,致密的中间层显然是有效捕获 B19V 的最关键功能层。含有 B19V 的蛋白质溶液的 Planova 过滤导致在致密中间层中出现 LRV>4 的分布峰,证明了过滤步骤的有效性。这是首次在实际生产条件下进行过滤过程时,同时分析病毒去除过滤器的宏观结构并可视化病毒捕获的报告。本研究中开发的方法学表明,过滤过程的病毒去除能力可以与宏观物理过滤器结构相关联,有助于更好地理解病毒捕获机制,并有助于开发更可靠和稳健的生物制品生产中的病毒过滤工艺。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e28/7003479/abe93dd3ebf3/BTPR-35-e2875-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验